Molecular markers (FGFR3 mutation; p53 and Ki-67 expression) and clinical outcome of radical cystectomy for bladder cancer: A multi-center, multi-laboratory study

2019 ◽  
Vol 18 (1) ◽  
pp. e819
Author(s):  
B.W.G. Van Rhijn ◽  
L. Mertens ◽  
R. Mayr ◽  
P. Bostrom ◽  
S.F. Shariat ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Molecular Markers ◽  
Clinical Outcome ◽  
Radical Cystectomy ◽  
Laboratory Study ◽  
Ki 67 ◽  
Fgfr3 Mutation

MP28-12 MOLECULAR MARKERS (FGFR3 MUTATION; P53 & KI-67 EXPRESSION) AND CLINICAL OUTCOME OF RADICAL CYSTECTOMY FOR BLADDER CANCER: A MULTICENTER, MULTILAB STUDY

2014 ◽  
Vol 191 (4S) ◽  
Author(s):  
Laura Mertens ◽  
Tahlita Zuiverloon ◽  
Yann Neuzillet ◽  
Shahrokh Shariat ◽  
Cheno Abas ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Molecular Markers ◽  
Clinical Outcome ◽  
Radical Cystectomy ◽  
Ki 67 ◽  
Fgfr3 Mutation

52 COMPARISON OF MOLECULAR MARKERS, SUB-STAGE AND THE EORTC RISK-SCORE TO PREDICT CLINICAL OUTCOME OF PT1 BLADDER CANCER

2010 ◽  
Vol 9 (2) ◽  
pp. 50
Author(s):  
B.W.G. Van Rhijn ◽  
T.H. Van Der Kwast ◽  
B. Bapat ◽  
P.J. Bostrom ◽  
N.E. Fleshner ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Molecular Markers ◽  
Clinical Outcome ◽  
Risk Score

765 THE FGFR3 MUTATION IDENTIFIES PATIENTS WITH FAVORABLE DISEASE AT RADICAL CYSTECTOMY FOR BLADDER CANCER

2011 ◽  
Vol 10 (2) ◽  
pp. 243 ◽  
Author(s):  
B.W.G. Van Rhijn ◽  
P.J. Bostrom ◽  
S.F. Shariat ◽  
A. Finelli ◽  
A.I. Sagalowsky ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Radical Cystectomy ◽  
Fgfr3 Mutation

1714 COMPARISON OF MOLECULAR MARKERS, SUB-STAGE AND THE EORTC RISK-SCORE TO PREDICT CLINICAL OUTCOME OF PT1 BLADDER CANCER

2010 ◽  
Vol 183 (4S) ◽  
Author(s):  
Bas van Rhijn ◽  
Theo van der Kwast ◽  
Bharati Bapat ◽  
Peter Bostrom ◽  
Neil Fleshner ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Molecular Markers ◽  
Clinical Outcome ◽  
Risk Score
Sign in / Sign up

Export Citation Format

Share Document